New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:03 EDTINSYInsys Therapeutics completes human abuse study for Dronabinol Oral Solution
Insys Therapeutics announced the successful completion of a human abuse study for Dronabinol Oral Solution, its proprietary, orally administered liquid formulation of the synthetic cannabinoid dronabinol in development for the treatment of chemotherapy induced nausea and vomiting, or CINV, and anorexia associated with weight loss in patients with AIDS.
News For INSY From The Last 14 Days
Check below for free stories on INSY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:14 EDTINSYInsys Therapeutics receives FDA orphan drug designation for CBD
Insys Therapeutics announced that the FDA has granted orphan drug designation, or ODD, to its pharmaceutical cannabidiol, CBD, for the treatment of glioma, which comprises approximately eighty percent of all malignant brain tumors. The ODD includes pontine glioma, a devastating form of primary brainstem glioma.
September 26, 2014
10:03 EDTINSYInsys Therapeutics receives orphan status for glioma treatment
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use